Cargando…

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention

It is valuable to establish a population‐based prevaccination baseline distribution of human papillomavirus (HPV) types among women with high‐grade cervical intraepithelial neoplasia (CIN) grade 2 or 3 and cervical cancer in order to assess the potential impact of HPV vaccination. In four countries...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dovey de la Cour, Cecilie, Guleria, Sonia, Nygård, Mari, Trygvadóttir, Laufey, Sigurdsson, Kristjan, Liaw, Kai‐Li, Hortlund, Maria, Lagheden, Camilla, Hansen, Bo T., Munk, Christian, Dillner, Joakim, Kjaer, Susanne K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Cancer Prevention
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382723/ https://www.ncbi.nlm.nih.gov/pubmed/30632704 http://dx.doi.org/10.1002/cam4.1961

Ejemplares similares

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
por: Nygård, Mari, et al.
Publicado: (2014)

Human papillomavirus self‐sampling with mRNA testing benefits routine screening
por: Auvinen, Eeva, et al.
Publicado: (2022)

Final analysis of a 14-year long-term follow-up study of the effectiveness and immunogenicity of the quadrivalent human papillomavirus vaccine in women from four nordic countries
por: Kjaer, Susanne K., et al.
Publicado: (2020)

Shared environment and colorectal cancer: A Nordic pedigree registry‐based cohort study
por: Elmahdi, Rahma, et al.
Publicado: (2022)

Cancer Registry follow‐up for 17 million person‐years of a nationwide maternity cohort
por: Lehtinen, Matti, et al.
Publicado: (2017)

Socioeconomic status and risk of lung cancer by histological subtype in the Nordic countries
por: Pizzato, Margherita, et al.
Publicado: (2022)

Finasteride treatment and male breast cancer: a register‐based cohort study in four Nordic countries
por: Meijer, Mathias, et al.
Publicado: (2017)

Effectiveness of various human papillomavirus vaccination strategies: A community randomized trial in Finland
por: Lehtinen, Matti, et al.
Publicado: (2021)

Geographical disparities in human papillomavirus herd protection
por: Berenson, Abbey B., et al.
Publicado: (2020)

Prevent cervical cancer by screening with reliable human papillomavirus detection and genotyping
por: Ge, Shichao, et al.
Publicado: (2012)

Selecting human papillomavirus genotypes to optimize the performance of screening tests among South African women
por: Johnson, Lauren G., et al.
Publicado: (2020)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

Diagnostic value of high‐risk human papillomavirus viral load on cervical lesion assessment and ASCUS triage
por: Wang, Min, et al.
Publicado: (2021)

Deep sequencing extends the diversity of human papillomaviruses in human skin
por: Bzhalava, Davit, et al.
Publicado: (2014)

Incidence and persistence of carcinogenic genital human papillomavirus infections in young women with or without Chlamydia trachomatis co-infection
por: Vriend, Henrike J, et al.
Publicado: (2015)

Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population
por: Radecki Breitkopf, Carmen, et al.
Publicado: (2016)

The prevalence, trends, and geographical distribution of human papillomavirus infection in China: The pooled analysis of 1.7 million women
por: Zhu, Bo, et al.
Publicado: (2019)

Genomic, transcriptomic, and viral integration profiles associated with recurrent/metastatic progression in high‐risk human papillomavirus cervical carcinomas
por: Liu, Jing Jing, et al.
Publicado: (2020)

Investigating the association between serum human papillomavirus type 16 E7 antibodies and risk of head and neck cancer
por: Huang, Cheng‐Chih, et al.
Publicado: (2021)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Distribution and role of high‐risk human papillomavirus genotypes in women with cervical intraepithelial neoplasia: A retrospective analysis from Wenzhou, southeast China
por: Wang, Yuli, et al.
Publicado: (2018)

Serial type-specific human papillomavirus (HPV) load measurement allows differentiation between regressing cervical lesions and serial virion productive transient infections
por: Depuydt, Christophe E, et al.
Publicado: (2015)

Age‐specific prevalence of human papillomavirus and abnormal cytology at baseline in a diverse statewide prospective cohort of individuals undergoing cervical cancer screening in Mississippi
por: Clarke, Megan A., et al.
Publicado: (2021)

Risk of squamous cell skin cancer after organ transplant associated with antibodies to cutaneous papillomaviruses, polyomaviruses, and TMC6/8 (EVER1/2) variants
por: Madeleine, Margaret M, et al.
Publicado: (2014)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Efficacy of careHPV™ human papillomavirus screening versus conventional cytology tests for the detection of precancerous and cancerous cervical lesions among women living with HIV‐1 in Lao People's Democratic Republic
por: Paboriboune, Phimpha, et al.
Publicado: (2022)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

Prevalence of high‐risk human papillomavirus after HPV‐vaccination in Denmark
por: Lynge, Elsebeth, et al.
Publicado: (2020)

Low‐grade gangliogliomas in adults: A population‐based study
por: Lin, Xiaoning, et al.
Publicado: (2020)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial
por: Elfström, K. Miriam, et al.
Publicado: (2021)

Impact of early palliative care according to baseline symptom severity: Secondary analysis of a cluster‐randomized controlled trial in patients with advanced cancer
por: Rodin, Rebecca, et al.
Publicado: (2022)

Epidemiological trends, relative survival, and prognosis risk factors of WHO Grade III gliomas: A population‐based study
por: Fang, Jun‐Hao, et al.
Publicado: (2019)

BMI trajectories and risk of overall and grade‐specific prostate cancer: An observational cohort study among men seen for prostatic conditions
por: Wang, Kai, et al.
Publicado: (2018)

Prior human papillomavirus‐16/18 AS04‐adjuvanted vaccination prevents recurrent high grade cervical intraepithelial neoplasia after definitive surgical therapy: Post‐hoc analysis from a randomized controlled trial
por: Garland, Suzanne M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0n8kuhg5vsh0ppmiga24b7rlsf